Dr. Claire Verschraegen MD
Oncologist | Medical Oncology
89 Beaumont Ave Given E214 Burlington VT, 05405About
Dr. Claire Verschraegen is an oncologist practicing in Burlington, VT. Dr. Verschraegen specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Verschraegen manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Free University Of Brussels Faculty Of Med and Pharmacy 1982
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Topoisomerase-I inhibitors in gynecologic tumors.
- The role of macrophages in antitumor defense of patients with ovarian cancer.
- Present knowledge of gynecologic sarcoma management.
- Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
- A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer.
- Synchronous primary cancers of the breast and cervix: planning multidisciplinary primary treatment [clinico-pathological conference].
- Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
- Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
- Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
- Estrogen replacement therapy and ovarian cancer.
- Alternative administration of camptothecin analogues.
- Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan.
- Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors.
- Maturation of dendritic cells from ovarian cancer patients.
- Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.
Dr. Claire Verschraegen MD's Practice location
Dr. Claire Verschraegen MD's reviews
Write ReviewPatient Experience with Dr. Verschraegen
Recommended Articles
- After Ovarian Cancer Diagnosis: What to Expect
No two people are going to experience their diagnosis of ovarian cancer in the same way. Although some emotions, such as shock and grief, are common feelings among those who are newly diagnosed with cancer, not everyone will feel their emotions in the same degree or in the same order. All cancer is...
- What Are the Symptoms of Pancreatic Cancer?
Pancreatic cancer is one of the most common cancers in the country, and is seen in both males and females at equal rates. Based on the location in the organ, pancreatic cancer is classified into two major types – exocrine pancreatic cancer and endocrine cancer. Exocrine cancer affects the part of...
- What Specialist Conducts Chemotherapy?
Chemotherapy is a very delicate and complicated procedure. This is because it also has the ability to cause further complications in a person’s health while it is being used to treat another medical condition. Chemotherapy usually has side effects that can be very severe.Therefore it requires well...
- Is Leukemia Hereditary?
Leukemia is a type of cancer that affects a person's blood cells, bone marrow, and lymphatic system. The symptoms associated with leukemia arise because of an increased level of immature or undeveloped white blood cells, also called leukocytes. This abnormality is caused by a mutation in the...
- Ovarian Cancer Vaccine Development: An Update
OncBioMune Pharmaceuticals, a clinical-stage bio-pharmaceutical company, is advancing its developments in vaccine technology to help boost the immune system to target cancer cells without causing harm to the patient. They have worked on prostate cancer vaccines and are working on ovarian cancer...
- What are the Stages of Melanoma?
Melanoma is a type of skin cancer which affects the melanocytes of the skin, which give skin its color. It is a malignant tumor and may develop from an existing mole or as a new mole. It being malignant means that it is a dangerous condition and can lead to death. The common sites they affect are...
Nearby Providers
- Dr. Marc Steven Greenblatt MD111 Colchester Ave Burlington VT 05401
- Dr. Dennis Allen Sanders M.D.792 College Pkwy Colchester VT 05446
- Dr. Johannes Christian Nunnink M.D.111 COLCHESTER AVE BURLINGTON VT 05401